“drug” or “drug product” include any substances of vegetable, animal or mineral
origin or any preparation or admixture thereof manufactured, sold or advertised for use
in:
(a) the diagnosis, treatment, mitigation, in man or animal;
(b) restoring, correcting or modifying organic function in man and animal;
(c) disinfections or the control of vermin, insects or pest; or
(d) contraception;
“expiry date” means any date after which a drug is not recommended for use;
“identification mark” means any single letter or combination of letters and numbers
including e.g. words, company, mark, symbol, logo or monogram or a combination of
letters, numbers and marks or symbols assigned by a drug firm to a specific drug product;
“inactive ingredient” means any component other than an active ingredient;
“ingredient” means any substance in the drug, whether added to the formulation as a
single substance or in admixture with other substances;
“inner label” means primary packaging material label;
“label” includes any legend, word or mark attached to, included in, belonging to or
accompanying any drug or package;
“lot or batch number” means the number or a combination of numbers and letters
specifically given to a drug which is linked to the manufacturing history of the drug;
“outer label” means secondary packaging material label;
“over- the-counter drug” means any drug other than a prescription drug;
“package” includes any suitable container in which any drug is wholly or partly placed
or packed;
“package components” include primary packaging material, secondary packaging
material or tertiary packaging material;
“parenteral use” means administration of a drug by means of hypodermic syringes,
needles or other instrument through or into the skin or mucous membrane;
“prescription drug” means a drug which can only be made available to a patient
through a written prescription signed by a duly qualified and registered medical or dental
practitioner or veterinary surgeon and dispensed by a registered and licenced pharmacist
10